These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34966451)

  • 1. Correlation between promoter methylation of the LDH-C4 gene and DNMT expression in breast cancer and their prognostic significance.
    Zhang J; Zhang F; Zhang F; Wu H; Zhang B; Wu X
    Oncol Lett; 2022 Jan; 23(1):35. PubMed ID: 34966451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
    Girault I; Tozlu S; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors.
    Jahangiri R; Mosaffa F; Emami Razavi A; Teimoori-Toolabi L; Jamialahmadi K
    J Cell Physiol; 2018 Sep; 233(9):7305-7319. PubMed ID: 29574992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-Testis Antigen LDH-C4 in Tissue, Serum, and Serum-Derived Exosomes Serves as a Promising Biomarker in Lung Adenocarcinoma.
    Peng W; Chen J; Xiao Y; Su G; Chen Y; Cui Z
    Front Oncol; 2022; 12():912624. PubMed ID: 35814471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of methylation of MAGE-A1 and-A3 promoters and expression of DNA methyltransferase in patients with laryngeal squamous cell carcinoma.
    Liu S; Zhao Y; Xu Y; Sang M; Zhao R; Gu L; Shan B
    Am J Otolaryngol; 2020; 41(1):102318. PubMed ID: 31732299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer.
    Cui Z; Chen Y; Hu M; Lin Y; Zhang S; Kong L; Chen Y
    Clin Chim Acta; 2020 Apr; 503():203-209. PubMed ID: 31794764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
    Roll JD; Rivenbark AG; Jones WD; Coleman WB
    Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Bai X; Fu Y; Xue H; Guo K; Song Z; Yu Z; Jia T; Yan Y; Zhao L; Mi X; Wang E; Zheng Z; Zhao H; Yao W; Wei M
    Oncol Lett; 2014 Apr; 7(4):1088-1096. PubMed ID: 24944674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.
    Bai X; Song Z; Fu Y; Yu Z; Zhao L; Zhao H; Yao W; Huang D; Mi X; Wang E; Zheng Z; Wei M
    PLoS One; 2012; 7(6):e40024. PubMed ID: 22768205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Jahangiri R; Jamialahmadi K; Gharib M; Emami Razavi A; Mosaffa F
    Gene; 2019 Feb; 685():24-31. PubMed ID: 30359738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer.
    Yang J; Wei X; Wu Q; Xu Z; Gu D; Jin Y; Shen Y; Huang H; Fan H; Chen J
    Mol Med Rep; 2011; 4(6):1139-43. PubMed ID: 21887466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of DNMT3B promoter methylation in breast cancer patients using differential high resolution melting analysis.
    Naghitorabi M; Mohammadi Asl J; Mir Mohammad Sadeghi H; Rabbani M; Jafarian-Dehkordi A; Javanmard HS
    Res Pharm Sci; 2013 Jul; 8(3):167-75. PubMed ID: 24019826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters DNA methyltransferase (dnmt) expression in zebrafish (Danio rerio).
    Aluru N; Kuo E; Helfrich LW; Karchner SI; Linney EA; Pais JE; Franks DG
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):142-51. PubMed ID: 25732252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis.
    Yu Z; Xiao Q; Zhao L; Ren J; Bai X; Sun M; Wu H; Liu X; Song Z; Yan Y; Mi X; Wang E; Jin F; Wei M
    Mol Carcinog; 2015 Sep; 54(9):707-19. PubMed ID: 24464625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.
    Fu D; Ren C; Tan H; Wei J; Zhu Y; He C; Shao W; Zhang J
    Medicine (Baltimore); 2015 Mar; 94(11):e637. PubMed ID: 25789956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.
    Li SY; Li R; Chen YL; Xiong LK; Wang HL; Rong L; Luo RC
    BMC Genet; 2014 Jun; 15():67. PubMed ID: 24919593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.
    Lin RK; Hsu HS; Chang JW; Chen CY; Chen JT; Wang YC
    Lung Cancer; 2007 Feb; 55(2):205-13. PubMed ID: 17140695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease.
    Ben Gacem R; Ben Abdelkrim O; Ziadi S; Ben Dhiab M; Trimeche M
    Tumour Biol; 2014 May; 35(5):4047-56. PubMed ID: 24375250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.
    Liu L; He Y; Ge G; Li L; Zhou P; Zhu Y; Tang H; Huang Y; Li W; Zhang L
    PLoS One; 2017; 12(8):e0182168. PubMed ID: 28767733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
    Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV
    Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.